ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672446 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672446; 2) Community: the network communities that were significantly associated with the response to NSC 672446; 3) Molecule: the relationships between components within communities and NSC 672446; 4) MDR: the compounds that were significantly associated with the NSC 672446.

NSC Compound Enrichment Correlation
NSC 730478 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-5-androsten-3.beta.,17.beta.-diol 0.0284045326811618 0.21750512
NSC 736807 Null 0.0284045326811618 0.013025709
NSC 744209 Null 0.0284045326811618 0.22180421
NSC 746058 Null 0.0284045326811618 0.040845191
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0284045326811618 0.066095105
NSC 754118 6-chloro-7-phenyl-8-(3,5-dimethoxybenzyl)- 5,8-dihydro-4H-isoxazolo[4,5-g]indole 0.0284045326811618 0.2067609
NSC 755465 Null 0.0284045326811618 0.24772933
NSC 757387 ACRIFLAVINIUM HYDROCHLORIDE 0.0284045326811618 0.33616789
NSC 104801 Cytembena 0.0286383688883668 -0.068629052
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0286383688883668 -0.11949592
Total:84  Current:48    [First] [Prev] [Next] [Last]